Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Renin and Renal Biomarker Response to Angiotensin II Versus Controls in Septic Shock: An Open-Label Study

NCT04558359 is registered in ClinicalTrials.gov with Alexander Flannery as lead sponsor.

NCT NCT04558359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04558359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Renin and Renal Biomarker Response to Angiotensin II Versus Controls in Septic Shock: An Open-Label Study
Lead sponsor
Alexander Flannery
Phase
Phase 4
Overall status
Completed
Start date
October 19, 2020
Completion date
July 30, 2023
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, septic shock